Nervous System Research Understanding neurological health remains a major scientific objective
Until studies of that design exist and agree, statements about GHK-Cu and hair growth remain at the level of mechanistically plausible and worth testing, which is precisely how a careful reader should hold them
The most commonly reported side effects are mild and transient, including injection site reactions (redness, slight swelling, or tenderness), mild headaches during the initial days of use, and occasional dizziness or lightheadedness, particularly when starting the peptide
However, starting retatrutide at a low dose is still recommended to assess tolerance of the glucagon receptor component specifically
So GHK-Cu = 50 mg 30 = 1.67 mg
The intranasal spray formulation provides additional scientific value by allowing laboratories to investigate formulation stability, spray consistency, peptide integrity, physicochemical characteristics, analytical reproducibility, and intranasal delivery system performance